• 11268 Citations
  • 50 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where SunYoung Rha is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
irinotecan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

1 Citation (Scopus)

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Kim, T. Y., Han, H. S., Lee, K. W., Zang, D. Y., Rha, S., Park, Y. I., Kim, J. S., Lee, K. H., Park, S. H., Song, E. K., Jung, S. A., Lee, N. M., Kim, Y. H., Cho, J. Y. & Bang, Y. J., 2019 Jan 1, In : Gastric Cancer.

Research output: Contribution to journalArticle

Paclitaxel
Stomach Neoplasms
Maximum Tolerated Dose
HM781-36B
Trastuzumab
2 Citations (Scopus)

Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial

Chung, H., Arkenau, H. T., Lee, J., Rha, S., Oh, D. Y., Wyrwicz, L., Kang, Y. K., Lee, K. W., Infante, J. R., Lee, S. S., Kemeny, M., Keilholz, U., Melichar, B., Mita, A., Plummer, R., Smith, D., Gelb, A. B., Xiong, H., Hong, J., Chand, V. & 1 others, Safran, H., 2019 Feb 4, In : Journal for ImmunoTherapy of Cancer. 7, 1, 30.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Maintenance
Disease-Free Survival
Neoplasms

Behaviors and attitudes toward the use of complementary and alternative medicine among Korean cancer patients

Kwon, J. H., Lee, S. C., Lee, M. A., Kim, Y. J., Kang, J. H., Kim, J. Y., Lee, H. J., Bae, W. K., Kim, M. J., Chie, E. K., Kim, J., Kim, Y. H., Chung, H. & Rha, S., 2019 Jul 1, In : Cancer Research and Treatment. 51, 3, p. 851-860 10 p.

Research output: Contribution to journalArticle

Open Access
Complementary Therapies
Neoplasms
Republic of Korea
Odds Ratio
Confidence Intervals
Symptom Assessment
Randomized Controlled Trials
Fatigue
Education
Neoplasms
1 Citation (Scopus)

Differences in the efficacies of pazopanib and gemcitabine/docetaxel as second-line treatments for metastatic soft tissue sarcoma

Kim, J. H., Park, H. S., Heo, S. J., Kim, S. K., Han, J. W., Shin, K. H., Kim, S. H., Hur, H., Kim, K. S., Choi, Y., Kim, S., Lee, Y. H., Suh, J., Ahn, J. B., Chung, H., Noh, S. H., Rha, S. & Kim, H. S., 2019 Feb 1, In : Oncology (Switzerland). 96, 2, p. 59-69 11 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Sarcoma
Therapeutics
Synovial Sarcoma